Publications by authors named "James McGovern"

Claim this Profile
A
A new parafocusing paradigm for X-ray diffraction.
Danae Prokopiou, James McGovern, Gareth Davies, Simon Godber, Paul Evans

J Appl Crystallogr· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of quality metrics for ambulatory pediatric cardiology: Infection prevention.
Jonathan N Johnson, Cindy S Barrett, Wayne H Franklin, Eric M Graham, Nancy J Halnon, James J McGovern

Congenit Heart Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer.
Tien Hoang, KyungMann Kim, Joseph Merchant, Anne M Traynor, James McGovern

J Thorac Oncol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study.
Brad S Kahl, Howard H Bailey, Eileen P Smith, Nancy Turman, Jamie Smith, James McGovern

Cancer Invest· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidosis.
Paul A McCarron, Ryan F Donnelly, Paul E Canning, James G McGovern, David S Jones

Biomaterials· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer.
Tien Hoang, KyungMann Kim, Anthony Jaslowski, Paul Koch, Peter Beatty, James McGovern

Lung Cancer· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer.
Glenn Liu, Kurt Oettel, Howard Bailey, Lynn Van Ummersen, Kendra Tutsch, James McGovern

Invest New Drugs· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicochemical characterization of hexetidine-impregnated endotracheal tube poly(vinyl chloride) and resistance to adherence of respiratory bacterial pathogens.
David S Jones, James G McGovern, A David Woolfson, Colin G Adair, Sean P Gorman

Pharm Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis